'Gas station heroin' is technically illegal and widely available. Here are the facts
Health officials want you to think twice before buying one of those brightly colored little bottles often sold at gas stations, convenience stores and smoke shops.
Sometimes called 'gas station heroin,' the products are usually marketed as energy shots or cognitive supplements but actually contain tianeptine, an unapproved drug that can be addictive and carries risks of serious side effects.
U.S. poison control centers have reported a steady rise in calls linked to the drug for more than a decade. And last month the Food and Drug Administration sent a warning to health professionals about 'the magnitude of the underlying danger or these products.'
Here's what to know about gas station heroin.
How are these products sold in the U.S.?
Tianeptine is approved in a number foreign countries as an antidepressant, usually as a low-dose pill taken three times a day. But it has never been approved by the FDA for any medical condition in the U.S.
Additionally, the drug cannot legally be added to foods and beverages or sold as a dietary supplement — something the FDA has repeatedly warned U.S. companies about.
Still, under-the-radar firms sell tianeptine in various formulas, often with brand names like Zaza, Tianaa, Pegasus and TD Red. Although that is technically illegal, the FDA does not preapprove ingredients added to supplements and beverages.
'It's kind of this grey area of consumer products, or supplements, where the contents are not regulated or tested the way they would be with a medication,' said Dr. Diane Calello of the New Jersey Poison Information and Education System.
Last year, Calello and her colleagues published a study documenting a cluster of emergency calls in New Jersey tied to a flavored elixir called Neptune's Fix. People experienced distress, rapid heartbeat, low blood pressure and seizures after drinking it. More than a dozen of the 20 patients had to be admitted for intensive care.
Why use these products?
Many tianeptine products claim— without evidence or FDA approval— to help users treat medical conditions, including addiction, pain and depression.
In 2018, the FDA issued a warning letter to the maker of a product called Tianna, which claimed to provide 'an unparalleled solution to cravings for opiates.'
While tianeptine is not an opioid, the drug binds to some of the same receptors in the brain, which can temporarily produce effects akin to oxycodone and other opioids. Tianeptine also carries some of the same physiological risks of opioids, including the potential to dangerously depress breathing.
'That's what tends to get people into trouble,' said Dr. Hannah Hays of Nationwide Children's Hospital in Columbus, Ohio. 'They use it for opioid-like effects or to self-treat opioid withdrawal and that can lead to slow breathing and problems like that."
People dealing with opioid addiction, pain, depression, anxiety and other conditions should see a health professional to get a prescription for FDA-approved treatments, Hays said.
Is tianeptine use going up?
Experts aren't sure but national figures show a big rise in emergency calls involving the drug.
Calls to poison control centers increased 525% between 2018 and 2023, according to a data analysis published earlier this year. In about 40% of cases, the person had to seek medical care, with more than half of them needing critical care.
One explanation for the rise in calls is simply that more Americans are using the products.
But experts also say that the products are triggering more emergencies as they become more potent and dangerous. And the researchers in New Jersey who analyzed Neptune's Fix found that the liquid also contained synthetic cannabis and other drugs.
'You never quite know what's in that bottle," Calello said. 'It's important for people to know that even if they have used a product before, they could get a bottle that contains something very different from what they're looking for.'
Are there policies that could reduce tianeptine use?
Tianeptine is not included in the federal Controlled Substances Act, which bans or restricts drugs that have no medical use or have a high potential for abuse, such as heroin, LSD and PCP. But about a dozen states have passed laws prohibiting or restricting tianeptine, including Alabama, Georgia, Michigan, Minnesota, Ohio and Tennessee.
In some cases, those laws have led to more cases of withdrawal among users of tianeptine, which can be chemically addictive. But state data also shows some success in reducing harm tied to the drug.
Until recently, Alabama had the highest rate of tianeptine-related calls in the southern U.S., which increased more than 1,400% between 2018 to 2021. But after the state restricted tianeptine in 2021 calls began modestly decreasing while calls across other southern states continued to climb.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
an hour ago
- Telegraph
This neuroscientist has the secret to tackling inflammation
Imagine a future where you no longer have to take a pill for your ill. No more monthly prescription charges or time-consuming trips to the doctor. No debilitating side-effects; all you'd need is an hour-long operation to insert a tiny electrical device in your chest and neck to calm the inflammation in your body. Inflammation is a natural process, and a certain amount is healthy and necessary. When a person becomes ill or injured, their immune system sends out its 'first responders' – inflammatory cells which start to heal the injured tissue. For example, a fever is evidence that your immune system is working properly. However, if this process continues for too long, inflammation can harm healthy tissues, and lead to chronic illness. Dr Kevin Tracey is a professor of neurosurgery at the Zucker School of Medicine in Long Island, New York, and the president and chief executive of the Feinstein Institute for Medical Research. 'Inflammation causes or contributes to the conditions that kill two thirds of people on the planet,' he says. 'Of the 60 million that die per year, 40 million die from inflammatory conditions such as heart disease, stroke, or cancer.' The key to fighting inflammation, according to Dr Tracey, is stimulation of the vagus nerve. The vagus nerve, which runs down your neck and into your chest and abdomen, is an anatomical 'superhighway' comprising a complex network of more than 200,000 fibres connecting the brain to vital organs. It is part of your parasympathetic nervous system, responsible for the body's 'rest and digest' functions. Dr Tracey is something of a pioneer in this area, which he investigates in his new book, The Great Nerve: The New Science of the Vagus Nerve and How To Harness Its Healing Reflexes, and he claims to be one of the most highly cited living scientists in the world. Scientists have known about the vagus nerve since the 16th century, but for Dr Tracey, a breakthrough came in 1998 when a laboratory experiment gone wrong led to an unexpected discovery. He and his colleagues accidentally injected a rat with an inflammatory toxin – and an anti-inflammatory drug simultaneously injected in its brain had a restorative effect. Until then, scientists thought that the brain and immune system did not communicate. The groundbreaking discovery on that that day gave way to to Dr Tracey and his colleagues realising that the vagus nerve wasn't just something that impacted the brain; it also controlled inflammation and, as a result, all areas of our health – from gut health to joints – and stimulating it could reduce harmful inflammation. 'It's obvious, at least to me, that this mode of treatment will soon be able to help millions who are suffering with inflammatory illnesses,' says Dr Tracey. A new era of medicine Thanks to ongoing research into the vagus nerve, the next decade could see vastly improved treatment of inflammatory illnesses such as rheumatoid arthritis and Crohn's disease. In fact, Dr Tracey's new bioelectronic treatment for rheumatoid arthritis – which like all vagus nerve stimulation (VNS) treatment works on the premise of 'turning off' an inflammatory molecule called TNF – is awaiting regulatory approval. Since Dr Tracey's initial breakthrough, research into the vagus nerve has accelerated, giving rise to a field known as 'bioelectronic medicine', where treatments use electrical signals rather than drugs. A pacemaker is an example of bioelectronic medicine, as is VNS, which some experts describe as 'a pacemaker for the brain'. VNS involves the implantation of a device that sends regular, mild pulses of electrical energy to your brain stem through your vagus nerve in your neck. After reaching your brainstem, the electrical charge is discharged to different areas of your brain to change the way brain cells work. 'Vagus nerve stimulation has saved lives,' says Dr Tracey. 'Many patients who turn to VNS have tried everything – they have run out of options. 'The advantages over medication are that it's more targeted than a pill, it has a short half-life – you can turn the treatment on and off – and it has fewer side-effects than many drugs,' he adds. Where VNS does work, it works miraculously. Dr Tracey tells the story of a lorry driver in one of his trials whose hands and feet were so affected by rheumatoid arthritis, he was unable to work. A week after being implanted with a vagal nerve stimulator the size of a pain-killing tablet, the driver was back to his normal life, even playing tennis. 'Meeting him was one of the happiest days of my professional life,' says Dr Tracey. 'Few scientists have the privilege of inventing something and then shaking hands with a patient it has helped. We're now getting emails from patients who are desperate for help. In one rheumatoid arthritis trial, we had room for 242 participants, but 20,000 people applied.' Should this new treatment be patented by the FDA in the United States, the chances of it rolling out internationally are high. 'There will be a surge of patient demand,' says Dr Tracey, who believes it could help 1,500,000 to two million rheumatoid arthritis patients in the US, and 17 million worldwide. 'Just imagine: a one-hour surgery rather than a lifetime on toxic drugs.' Farther into the future, says Dr Tracey, there may even be a VNS treatment for dementia. 'The link between Alzheimer's and inflammation is often talked about, but not well understood,' he says. 'But there is some evidence that VNS can enhance learning or memory.' Will VNS become mainstream? Even Dr Tracey accepts that VNS is not a fail-safe treatment, and that it only benefits about two thirds of patients. He knows that many traditional doctors still raise their eyebrows. 'Early advocates of VNS may be criticised by those defending the status quo, and who will say the 'effect' size of VNS is too small,' he says. 'Other, less benign forces may also hinder the adoption of vagal nerve stimulation, because this idea has the potential to disrupt the pharmaceutical industry.' He is keenly aware that it's not in the interests of big pharma to invest in trials for a product that will make their products redundant – hence Dr Tracey's trials are funded by venture capital. 'I actually wrote my book for doctors to read, as well as for laypeople,' he says. 'My mission is to shorten the adoption curve of a new technology. I'm an introvert rather than an extrovert: I don't want the limelight personally. But I want the facts to be in the limelight.' In Dr Tracey's eyes, the facts are clear: it's a low-risk treatment, with a high reward for those who do respond. 'I expect that vagus nerve therapy, like every other therapy, will not work in 100 per cent of patients,' he says. 'VNS has three possible outcomes. Those who respond are in remission, and others are much better and need less medication.' On those who do not respond at all, he says: 'There is still more work to do. But I fully expect that millions of people with inflammatory conditions will soon be helped by this therapy.' He dreams that it will become a preventative treatment, for conditions such as atherosclerosis, diabetes or cancer. 'For those people who have exhausted the gamut of drug treatments, VNS represents hope – from the woman whose arthritic hands are so twisted she cannot do up her blouse, to the man unable to work or play with his small children because of the debilitating pain in his wrists and hands. 'VNS is not a cure-all, but for many patients, it's a possible. And as a neurosurgeon and scientist, I love to chase the possible.' DIY stimulation of the vagus nerve for stress and anxiety What about the miracle cures we see everywhere on the internet, from meditating to breathwork and plunging into ice-water? Dr Tracey has a healthy scepticism. 'A clinical trial of one or two subjects is more like a fairy tale with a happy ending than scientific proof that the cold makes you healthier and stronger,' he says. 'In some cases, there is deep science, in others, not that much.' Regulated breathing seems to have more evidence than meditation or coldwater plunges. 'These things are important, but it's important not to overhype, or oversell them. It devalues the science that we do know. I don't want to dilute my vagus nerve work for over 30 years,' he says. On the other hand, says Dr Tracey, if these methods work for you, they work for you. He meditates, takes cold showers, and practices deep breathing every morning.
BBC News
3 hours ago
- BBC News
Herne Bay man has bladder tumours treated as NHS outpatient
A father-of-four has had bladder tumours removed as an outpatient at a Kent hospital through a pioneering new Payne, from Herne Bay, watched on-screen as surgeons removed a small tumour from his bladder via a procedure known as trans urethral laser 67-year-old, who underwent the procedure last week at Kent and Canterbury Hospital, says he was "absolutely blown over by the experience and the technology".Mr Payne had a previous tumour removed under general anaesthetic four years ago at an East Kent Hospitals University NHS Foundation Trust hospital. He said he was "a little bit nervous" before undergoing the new procedure, as he feared it might not be as effective."But it was exactly the same, just without the general anaesthetic," he said."I watched it on screen. I could see everything, and it was just like watching a documentary. I was even able to direct the consultant to where the tumour was." 'Major step forward' The procedure saw lead consultant for superficial bladder cancer, Georgios Papadopoulos, insert a thin flexible tube with a camera and light into Mr Payne's then took biopsies of the tumour before it was removed using a laser. Any remaining cancer cells were killed using chemotherapy. Mr Papadopoulos said: "This is a major step forward in how we treat patients with small tumours in their bladder."The Prostate Cancer Support Association Kent donated two laser machines, while the League of Friends of the Kent and Canterbury Hospital also helped provide funding.
The Independent
4 hours ago
- The Independent
‘I'll use private sector to help clear NHS backlog', says Streeting
Wes Streeting has said he will consider leaning more heavily on the private sector as he bids to clear NHS waiting lists. The health secretary said he will not be 'bound by outdated ideological battles' when tackling the crisis in the service, where 7.39 million people are currently waiting to be seen by doctors. He said it would be 'foolish to turn away' from the private healthcare sector, but cautioned that 'we must see it for what it is'. Writing in the Sunday Telegraph, Mr Streeting said: 'Some ask if using private capacity contradicts NHS principles. Nonsense. What contradicts NHS principles is letting people suffer unnecessarily when capacity exists to treat them. 'The treatment remains free at the point of use – that's what matters. The independent healthcare sector won't affect this principle, and so it would be foolish to turn it away when we so desperately need it in certain specialities. But at the same time, we must see it for what it is.' The health secretary, who previously received treatment for kidney cancer, added: ' Cancer taught me that time is precious. When you're waiting for treatment, every day matters. That's why I won't waste a single day, or a single available appointment slot, in our mission to give patients the care they deserve.' His comments are likely to spark uproar from MPs on the left of the Labour Party, who fiercely opposed expanding the role of the private sector under Jeremy Corbyn. The former Labour leader has previously accused Sir Keir Starmer of 'betraying' the health service for relying more on private care. The government has said partnerships with the private sector under Labour so far have delivered more than 500,000 treatments, with waiting lists having fallen to a two-year low of 7.39 million in April. Darren Grewcock, a security guard, had hip replacement surgery at the Meriden Hospital through a full NHS referral after an injury left him unable to work. He said: 'The X-rays revealed that I had bone-on-bone osteoarthritis on my left hip. I was referred for surgery and given a list of places you can go – which included options in the independent sector. 'Within three days of booking, I had an appointment booked with the consultant. I couldn't believe how quickly he got back to me and the process started. My recovery has been a huge success. I am fitter, stronger, and more mobile than I was at 50." The charity, Patients Association, welcomed the greater role of the private sector in the NHS. Chief executive Rachel Power said: 'As the NHS continues to tackle the backlog, communication and choice must remain central to how care is delivered because patients don't just need treatment, they need to feel informed and empowered.'
